VIDEO: Eyevance lays out offerings for anterior segment

SAN FRANCISCO — At the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology meeting, Jerry St. Peter, CEO and co-founder of Eyevance Pharmaceuticals, discusses the company’s latest developments in offering anterior segment and ocular surface therapies.

Full Story →